Singapore markets closed

Chimerix, Inc. (CMRX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
5.65-0.25 (-4.24%)
At close: 04:00PM EST
5.50 -0.15 (-2.65%)
After hours: 07:59PM EST
Full screen
Trade prices are not sourced from all markets
Previous close5.90
Open6.05
Bid5.63 x 1800
Ask5.93 x 2200
Day's range5.57 - 6.10
52-week range3.86 - 11.57
Volume1,442,432
Avg. volume978,473
Market cap490.773M
Beta (5Y monthly)1.44
PE ratio (TTM)N/A
EPS (TTM)-1.84
Earnings date23 Feb 2022 - 28 Feb 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est18.17
  • Motley Fool

    Chimerix (CMRX) Q3 2021 Earnings Call Transcript

    With me on today's call are president and chief executive officer, Mike Sherman; chief financial and business officer, Mike Andriole; Allen Melemed, our chief medical officer; and Josh Allen, our chief technology officer of Imipridones. Before we begin, I would like to remind you that the statements made on today's call include forward-looking statements within the meaning of the Private Litigation Reform Act of 1995 and are subject to risks and uncertainties, and other factors.

  • Zacks

    Chimerix (CMRX) Reports Q3 Loss, Lags Revenue Estimates

    Chimerix (CMRX) delivered earnings and revenue surprises of 0.00% and -72.56%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

  • Zacks

    Analysts Estimate Chimerix (CMRX) to Report a Decline in Earnings: What to Look Out for

    Chimerix (CMRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.